449 related articles for article (PubMed ID: 2496354)
1. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
[TBL] [Abstract][Full Text] [Related]
2. Elective conversion from cyclosporin to azathioprine in living related donor kidney transplants.
Sobh MA; Eldein AB; Moustafa FE; Ghoneim MA
Nephrol Dial Transplant; 1987; 2(4):258-60. PubMed ID: 3118269
[TBL] [Abstract][Full Text] [Related]
3. [14 years of kidney transplantation in children. Results with special reference to cyclosporin A treatment].
Brodehl J; Pichlmayr R; Offner G
Monatsschr Kinderheilkd; 1985 Oct; 133(10):771-3. PubMed ID: 3906380
[TBL] [Abstract][Full Text] [Related]
4. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
[TBL] [Abstract][Full Text] [Related]
5. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL
Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792
[TBL] [Abstract][Full Text] [Related]
6. [Results, over a 3-year, period of a triple combination: cyclosporin, azathioprine, prednisolone in high-risk kidney transplants].
Hiesse C; Rieu P; Neyrat N; Charpentier B; Benoit G; Bellamy J; Fries D
Nephrologie; 1987; 8(3):127-9. PubMed ID: 3309700
[TBL] [Abstract][Full Text] [Related]
7. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
8. Renal transplantation in children using cyclosporin A and azathioprine.
Clark AG; Rigden SP; Welsh KI; Bewick M; Koffman G; Haycock GB; Chantler C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1685-6. PubMed ID: 2652552
[No Abstract] [Full Text] [Related]
9. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe?
Cassidy MJ; Irving E; Swanepoel CR; Pascoe MD; van Zyl-Smit R; Jacobson JE
S Afr Med J; 1986 Sep; 70(6):317-8. PubMed ID: 3529454
[TBL] [Abstract][Full Text] [Related]
10. Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation.
Hall BM; Tiller DJ; Horvath JS; Duggin GG; Johnson JR; Roy LP; Hurley B; Harris JP; Rogers JR; Stephen MS
Med J Aust; 1985 Feb; 142(3):179-85. PubMed ID: 3881654
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression by Cyclosporin A in human renal transplant recipients.
Ringdén O; Bergstrand A; Collste H; Grimfors G; Lundgren G; Groth CG
Scand J Urol Nephrol Suppl; 1981; 64():220-9. PubMed ID: 6755683
[TBL] [Abstract][Full Text] [Related]
12. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
Maddux MS; Veremis SA; Pollak R; Mozes MF
Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
[TBL] [Abstract][Full Text] [Related]
13. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
14. [Results of conversion from conventional immunosuppressive therapy to cyclosporin A in complications following kidney transplantation].
Scholz D; Blank W; Bärwolf C; Ditscherlein G; Christenfeld R; Hüller H
Z Urol Nephrol; 1990 Feb; 83(2):69-76. PubMed ID: 2368516
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
[TBL] [Abstract][Full Text] [Related]
16. [Survival of grafts in the first 100 renal transplants at the Carlos van Buren Hospital].
Poblete H; Toro J; Nicovani V; Cevallos M; Orriols M
Rev Med Chil; 2001 Jul; 129(7):763-72. PubMed ID: 11552445
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
18. Conversion from cyclosporine to azathioprine in renal graft recipients.
MacDonald AS; Belitsky P; Gupta R; Bitter-Suermann H; Campbell R; Cohen A; Lannon SG
Transplant Proc; 1985 Aug; 17(4):1940-2. PubMed ID: 3895634
[TBL] [Abstract][Full Text] [Related]
19. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
20. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
